GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Longevity Biomedical Inc (NAS:LBIO) » Definitions » Cash Flow from Discontinued Operations

Longevity Biomedical (Longevity Biomedical) Cash Flow from Discontinued Operations : $0.00 Mil (TTM As of . 20)


View and export this data going back to 2050. Start your Free Trial

What is Longevity Biomedical Cash Flow from Discontinued Operations?

Cash flow from discontinued operations is the cash received by a company that comes from the sale of part of business.

Longevity Biomedical's cash flow from discontinued operations for the six months ended in . 20 was $0.00 Mil. It means Longevity Biomedical received $0.00 Mil from the sale of part of business quarterly. Longevity Biomedical's cash flow from discontinued operations for the trailing twelve months (TTM) ended in . 20 was $0.00 Mil.


Longevity Biomedical Cash Flow from Discontinued Operations Historical Data

The historical data trend for Longevity Biomedical's Cash Flow from Discontinued Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Longevity Biomedical Cash Flow from Discontinued Operations Chart

Longevity Biomedical Annual Data
Trend
Cash Flow from Discontinued Operations

Longevity Biomedical Semi-Annual Data
Cash Flow from Discontinued Operations

Longevity Biomedical Cash Flow from Discontinued Operations Calculation

Cash received by a company that comes from the sale of part of business.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Cash Flow from Discontinued Operations for the trailing twelve months (TTM) ended in . 20 was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Longevity Biomedical Cash Flow from Discontinued Operations Related Terms

Thank you for viewing the detailed overview of Longevity Biomedical's Cash Flow from Discontinued Operations provided by GuruFocus.com. Please click on the following links to see related term pages.


Longevity Biomedical (Longevity Biomedical) Business Description

Industry
Comparable Companies
Traded in Other Exchanges
N/A
Address
12100 NE 195th street, Suite 150, Bothell, WA, USA, 98011
Longevity Biomedical Inc is a clinical-stage biomedical company. The company is focused on the advancement of new technologies across therapeutics, monitoring, and digital health that aim to restore tissue form and function to increase health span. Longevity is acquiring a differentiated therapeutic pipeline of late-stage clinical technologies across ophthalmology, cardiovascular disease, and soft tissue reconstruction and repair.

Longevity Biomedical (Longevity Biomedical) Headlines

No Headlines